October 3, 2026 · 2 min read

Epitalon: the pineal tetrapeptide and what its telomerase research actually shows

A balanced look at epitalon (epithalon), a four-amino-acid peptide studied for telomerase induction, including the limits of the published evidence.

Epitalon (also spelled epithalon or epithalone) is a tetrapeptide with the sequence Ala-Glu-Asp-Gly, or AEDG. It was designed from the amino acid makeup of epithalamin, an extract of bovine pineal gland. You will usually see it mentioned alongside telomeres and aging, so this piece looks at what the papers support.

The epitalon sequence

Sequence: Alanine, Glutamic acid, Aspartic acid, Glycine.

  • Hydrophobic
  • Negatively charged
  • Glycine or proline
Length
4 amino acids
Average mass
390.35 Da
Formula
C14H22N4O9
Ala-Glu-Asp-Gly. Sequence from the cited 2025 review (Araj et al.); mass checked against PubChem (CID 219042).

The telomerase paper

Telomeres are protective caps on the ends of chromosomes. They shorten each time a cell divides, and the enzyme telomerase can rebuild them. In a 2003 paper in Bulletin of Experimental Biology and Medicine, Khavinson and colleagues added epithalon to cultures of human fetal fibroblasts that had no telomerase. They reported expression of the enzyme's catalytic subunit, enzyme activity, and telomere elongation, and suggested the telomerase gene had been reactivated. A 2004 paper from the same group reported that the peptide helped cells get past their usual division limit.

What the 2003 and 2004 papers reported

  1. 1

    Epithalon added

    To cells that had no telomerase.

  2. 2

    Enzyme

    Catalytic subunit expressed and activity detected.

  3. 3

    Telomeres

    Elongated.

  4. 4

    Division limit

    The 2004 paper reports cells passing their usual limit.

Khavinson et al., Bull Exp Biol Med 2003 and 2004, in cultured human fetal fibroblasts.

The broader review

A 2025 review in the International Journal of Molecular Sciences covers 25 years of in vitro, in vivo and in silico work. It reports geroprotective and neuroendocrine effects, tied to antioxidant, neuroprotective and antimutagenic activity. Among the specifics are an influence on melatonin synthesis, changes in interleukin-2 mRNA, modulation of thymocyte activity, and effects on several enzymes, telomerase among them.

Gaps in the evidence

That same review is frank about what is missing. It says it remains uncertain whether the effects it describes are the only mechanisms, and that physico-chemical and structural studies of the peptide are still quite limited. Much of the foundational work comes from one research group, and independent replication in modern cell systems or controlled human studies is sparse.

  • Higher telomerase activity in cultured cells doesn't show an effect on aging in a whole organism.
  • Telomere biology is sensitive to culture conditions, so replication carries a lot of weight.
  • With so little structural data, batch-level analytical characterization matters more.

What the papers do and don't show

  1. Cultured cells

    Telomerase and telomere findings reported.

  2. Whole organism aging

    Not shown by these telomerase papers.

  3. Independent replication

    Sparse.

Based on the 2025 review (Araj et al.) and the primary papers. Not a systematic review.

Four amino acids make epitalon easy to synthesize, but quality still varies. The certificate of analysis should show HPLC purity and a mass spec result matching the expected 390.35 g/mol.

References

  1. Khavinson VKh et al. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med 2003.
  2. Khavinson VKh et al. Peptide promotes overcoming of the division limit in human somatic cell. Bull Exp Biol Med 2004.
  3. Araj SK et al. Overview of Epitalon: Highly Bioactive Pineal Tetrapeptide with Promising Properties. Int J Mol Sci 2025.